Department of Hematology
Gerrit J. Schuurhuis has not added Biography.
If you are Gerrit J. Schuurhuis and would like to personalize this page please email our Author Liaison for assistance.
Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts.
Journal of hematotherapy & stem cell research Dec, 2002 | Pubmed ID: 12590710
Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
Haematologica Feb, 2003 | Pubmed ID: 12604403
Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia.
Haematologica May, 2003 | Pubmed ID: 12745269
Novel multiparameter flow cytometry assay using Syto16 for the simultaneous detection of early apoptosis and apoptosis-corrected P-glycoprotein function in clinical samples.
Cytometry. Part B, Clinical cytometry Sep, 2003 | Pubmed ID: 12949955
Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cells.
Haematologica Sep, 2003 | Pubmed ID: 12969806
Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosis.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2005 | Pubmed ID: 15814631
Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2005 | Pubmed ID: 16000576
Flow cytometric evaluation of PI3K/Akt and MAPK/ERK activation.
Haematologica Jun, 2006 | Pubmed ID: 16769567
Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells.
Stem cells and development Feb, 2007 | Pubmed ID: 17348807
Activated intrinsic apoptosis pathway is a key related prognostic parameter in acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr, 2007 | Pubmed ID: 17401010
Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2007 | Pubmed ID: 18056177
Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
Cytometry. Part B, Clinical cytometry Jan, 2008 | Pubmed ID: 18061946
Concurrent methylation of promoters from tumor associated genes predicts outcome in acute myeloid leukemia.
Leukemia & lymphoma Jun, 2008 | Pubmed ID: 18569637
Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia.
Haematologica Jan, 2009 | Pubmed ID: 19042917
Towards cure of CML: why we need to know more about CML stem cells?
Current stem cell research & therapy Sep, 2009 | Pubmed ID: 19492977
Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer.
Current pharmaceutical design , 2013 | Pubmed ID: 22973962
Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
PloS one , 2013 | Pubmed ID: 24244383
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group.
Pediatric blood & cancer Oct, 2014 | Pubmed ID: 24976003
Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia.
PloS one , 2014 | Pubmed ID: 25244440
Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis.
Molecular & cellular proteomics : MCP Apr, 2016 | Pubmed ID: 26801919
How to assess minimal residual disease in pediatric and adult acute myeloid leukemia?
Translational pediatrics Apr, 2013 | Pubmed ID: 26835296
The interference of genetic associations in establishing the prognostic value of the immunophenotype in acute myeloid leukemia.
Cytometry. Part B, Clinical cytometry Jan, 2018 | Pubmed ID: 28646564
Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party.
Blood Jan, 2018 | Pubmed ID: 29330221
Jacqueline Cloos*,1,2,
Jeffrey R. Harris*,3,
Jeroen J.W.M. Janssen1,
Angele Kelder1,
F. Huang3,
Gerrit Sijm1,
Maike Vonk1,
Alexander N. Snel1,
Jennifer R. Scheick1,
Willemijn J. Scholten1,
Jannemieke Carbaat-Ham1,
Dennis Veldhuizen1,
Diana Hanekamp1,
Yvonne J.M. Oussoren-Brockhoff1,
Gertjan J.L. Kaspers2,4,
Gerrit J. Schuurhuis1,
A. Kate Sasser3,
Gert Ossenkoppele1
Copyright © 2024 MyJoVE Corporation. 판권 소유